These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9410898)

  • 41. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense.
    Trapnell BC; Whitsett JA
    Annu Rev Physiol; 2002; 64():775-802. PubMed ID: 11826288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.
    Suzuki T; Sakagami T; Rubin BK; Nogee LM; Wood RE; Zimmerman SL; Smolarek T; Dishop MK; Wert SE; Whitsett JA; Grabowski G; Carey BC; Stevens C; van der Loo JC; Trapnell BC
    J Exp Med; 2008 Nov; 205(12):2703-10. PubMed ID: 18955570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.
    Suzuki T; Sakagami T; Young LR; Carey BC; Wood RE; Luisetti M; Wert SE; Rubin BK; Kevill K; Chalk C; Whitsett JA; Stevens C; Nogee LM; Campo I; Trapnell BC
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1292-304. PubMed ID: 20622029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor.
    Geijsen N; Spaargaren M; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
    Oncogene; 1999 Sep; 18(36):5126-30. PubMed ID: 10490850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: evidence for a mutation hotspot in exon 4.
    Lin Z; deMello DE; Wallot M; Floros J
    Mol Genet Metab; 1998 May; 64(1):25-35. PubMed ID: 9682215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation.
    Nishinakamura R; Wiler R; Dirksen U; Morikawa Y; Arai K; Miyajima A; Burdach S; Murray R
    J Exp Med; 1996 Jun; 183(6):2657-62. PubMed ID: 8676086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary Alveolar Proteinosis: recent advances.
    Mazzone PJ; Jane Thomassen M; Kavuru MS
    Semin Respir Crit Care Med; 2002 Apr; 23(2):115-26. PubMed ID: 16088604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor.
    Tanaka N; Watanabe J; Kitamura T; Yamada Y; Kanegasaki S; Nakata K
    FEBS Lett; 1999 Jan; 442(2-3):246-50. PubMed ID: 9929010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D; Tang XM; Ma C; Chegini N
    Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct changes in pulmonary surfactant homeostasis in common beta-chain- and GM-CSF-deficient mice.
    Reed JA; Ikegami M; Robb L; Begley CG; Ross G; Whitsett JA
    Am J Physiol Lung Cell Mol Physiol; 2000 Jun; 278(6):L1164-71. PubMed ID: 10835321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surfactant proteins in pulmonary alveolar proteinosis in adults.
    Brasch F; Birzele J; Ochs M; Guttentag SH; Schoch OD; Boehler A; Beers MF; Müller KM; Hawgood S; Johnen G
    Eur Respir J; 2004 Sep; 24(3):426-35. PubMed ID: 15358702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
    Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA
    Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Out of breath: GM-CSFRalpha mutations disrupt surfactant homeostasis.
    Notarangelo LD; Pessach I
    J Exp Med; 2008 Nov; 205(12):2693-7. PubMed ID: 19015311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.
    Dranoff G; Crawford AD; Sadelain M; Ream B; Rashid A; Bronson RT; Dickersin GR; Bachurski CJ; Mark EL; Whitsett JA
    Science; 1994 Apr; 264(5159):713-6. PubMed ID: 8171324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism.
    Tredano M; De Blic J; Griese M; Fournet JC; Elion J; Bahuau M
    Clin Chem Lab Med; 2001 Feb; 39(2):90-108. PubMed ID: 11341756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous
    Shima K; Arumugam P; Sallese A; Horio Y; Ma Y; Trapnell C; Wessendarp M; Chalk C; McCarthy C; Carey BC; Trapnell BC; Suzuki T
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L438-L448. PubMed ID: 35043685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GM-CSF pathway correction in pulmonary alveolar proteinosis.
    Antoniu SA
    Expert Opin Biol Ther; 2010 Sep; 10(9):1357-65. PubMed ID: 20695835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The beta subunit common to the GM-CSF, IL-3 and IL-5 receptors is highly polymorphic but pathogenic point mutations in patients with acute myeloid leukaemia (AML) are rare.
    Freeburn RW; Gale RE; Wagner HM; Linch DC
    Leukemia; 1996 Jan; 10(1):123-9. PubMed ID: 8558916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.